Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 30/09/2008

    Harald Krug is investigating the use of new materials

    Prof. Dr. Harald Krug a toxicologist who runs the Materials-Biology Interaction division at Empa - Swiss Federal Laboratories for Materials Testing and Research in St. Gallen Switzerland and his team are investigating the interactions of synthetic materials with biological systems. The team of 25 researchers is focusing in particular on the effect of particles and nanomaterials such as CNT on human and animal cells. The division has been an…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-krug-is-investigating-the-use-of-new-materials
  • Dossier - 29/09/2008 This computer-based picture shows a small blue and red coloured molecule that fits into a gap of a large grey molecule. Such molecular interactions are essential for pharmacological research.

    Drug screening - higher throughput, quicker and more effective thanks to automation

    Over the last few years automation has revolutionised the search for pharmaceutical compounds. Using methods such as high-throughput screening or high-content screening it is possible to analyse thousands of molecule activities very quickly.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/drug-screening-higher-throughput-quicker-and-more-effective-thanks-to-automation
  • Article - 08/09/2008

    Research increases hope

    Duchenne muscular dystrophy DMD is a severe disease affecting boys characterised by rapid progression of muscle degeneration so that boys as young as 10 to 12 years of age have to use a wheelchair and leading to death in young men. In Germany about 2500 children and young adults suffer from DMD.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-increases-hope
  • Article - 30/08/2008

    Plant viruses: Summer School teaches diagnosis and analysis

    Researchers at the University of Stuttgart are leaders in the field of diagnosis and analysis of plant viruses. In a two-week Summer School the researchers imparted their knowledge to virologists from all over the world.

    https://www.gesundheitsindustrie-bw.de/en/article/news/plant-viruses-summer-school-teaches-diagnosis-and-analysis
  • Press release - 28/08/2008

    Günther Schütz and the regulation of gene expression by nuclear receptors

    Professor Dr. Günther Schützs work on the cell- and development-specific gene regulation using nuclear receptors has led amongst other things to new insights into the steroid hormone-dependent early development and differentiation of the nervous system the molecular mechanisms of learning and the development and regulation of drug addiction. Schütz has now been appointed Helmholtz professor which will enable him to continue his work beyond…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guenther-schuetz-and-the-regulation-of-gene-expression-by-nuclear-receptors
  • Article - 26/08/2008

    Regulation through protein degradation

    Proteins that are involved in the development of an organism must be activated at the right time and then inactivated if no longer required. Scientists in Tübingen investigate the specific degradation of these proteins through specialised and highly selective systems of the cell.

    https://www.gesundheitsindustrie-bw.de/en/article/news/regulation-through-protein-degradation
  • Article - 25/08/2008 import_03396_de.jpg

    Markers that reveal the correct biological age

    Researchers at the University of Ulm have just identified a number of proteins that reveal the biological age of a person. These biomarkers might be used in medical applications to adapt the medical treatment of older people to their individual biological age.

    https://www.gesundheitsindustrie-bw.de/en/article/news/markers-that-reveal-the-correct-biological-age
  • Press release - 24/08/2008

    Enzyme substitutions involving recombinant DNA technology

    Worldwide less than 10000 people suffer from Gauchers disease which is the most common lysosomal storage disease. Genzyme has been offering the drug Cerezyme for the treatment of this rare genetic disease since 1994. The companys subsidiary in Constance markets and sells this enzyme replacement therapy in Europe and Asia. The active substance is produced in Chinese hamster ovary cell cultures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/enzyme-substitutions-involving-recombinant-dna-technology
  • Article - 18/08/2008

    The unnoticed bacterium

    In contrast to the USA human granulocytic anaplasmosis infection rarely occurs in Germany. Dr. Friederike von Loewenich at the Freiburg Institute for Medical Microbiology and Hygiene are investigating the reason for this discrepancy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-unnoticed-bacterium
  • Press release - 02/08/2008

    Hölle & Hüttner - takeover of the share capital of INTAVIS AG

    Tübingen-based Hölle & Hüttner AG is taking over the entire share capital of Cologne-based INTAVIS Bioanalytical Instruments AG retroactively as of 1 January 2008. Both companies specialise in the development and marketing of systems for the automation of biochemical and molecular biological processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hoelle-huettner-takeover-of-the-share-capital-of-intavis-ag
  • Article - 21/07/2008

    Basic plant research provides insights into cancer research

    Claus Schwechheimer at the Centre for Plant Molecular Biology at the University of Tübingen has succeeded in identifying a protein function in plants which if it is understood might lead to important progress in human cancer research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/basic-plant-research-provides-insights-into-cancer-research
  • Article - 21/07/2008

    Eurofins GeneScan - Detecting unwanted ingredients

    In the EU it is mandatory to adequately label genetically modified food or animal feed. But how can producers make sure that their products are free from genetically modified organisms? The company Eurofins GeneScan GmbH from Freiburg can help.

    https://www.gesundheitsindustrie-bw.de/en/article/news/eurofins-genescan-detecting-unwanted-ingredients
  • Article - 17/07/2008

    Communication platform for researchers

    SciLife is a new virtual presentation and communication platform for the scientific community. The platform is now also available free of charge to researchers who want to increase networking activities and who are looking for equipment and researchers.

    https://www.gesundheitsindustrie-bw.de/en/article/news/communication-platform-for-researchers
  • Press release - 20/06/2008

    Refusal of Suicide Order: Why Tumor Cells Become Resistant

    Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body. Scientists at the German Cancer Research Center have now discovered a possible cause of this failure.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/refusal-of-suicide-order-why-tumor-cells-become-resistant
  • Article - 13/06/2008

    Basic research with a focus on application

    In the Centre of Applied Photonics CAP at the University of Constance interdisciplinary teams of researchers are working on new optical technologies with a special focus on laser technology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/basic-research-with-a-focus-on-application
  • Article - 02/06/2008

    Genome vagabonds

    Mobile DNA elements are able to change their position in the genome and mobilise entire gene groups as well as switch genes on and off. Professor Bodo Rak and his team at the University of Freiburg are investigating the effect of mobile DNA fragments on the evolution of E. coli bacteria.

    https://www.gesundheitsindustrie-bw.de/en/article/news/genome-vagabonds
  • Press release - 29/05/2008

    To fight the Cancer before the Tumour grows

    Researchers in Heidelberg have discovered a new strategy for an immunization against certain forms of cancer. They have determined that immune cells react strongly to the modified proteins in tumor cells in which a DNA repair defect has occurred. It is estimated that this repair defect is present in some 15 percent of all tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/to-fight-the-cancer-before-the-tumour-grows
  • Press release - 26/05/2008

    Excellent software - excellent service

    Karlsruhe based quantiom bioinformatics has developed a software tool that enables the comparative analysis of chromosomes and that enables statements to be made on the correlation of genomic alterations and disease development.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/excellent-software-excellent-service
  • Article - 20/05/2008

    Albrecht Sippel - A geneticist with a philosophical touch

    After years of directing his focus more on the molecular processes in the development of different cell types Prof. Albrecht Sippel has gone back to his roots. Despite his retirement six months ago Sippel started to actively participate in the search for human genes in the faculties of thought and speech that distinguish us from our animal relatives.

    https://www.gesundheitsindustrie-bw.de/en/article/news/albrecht-sippel-a-geneticist-with-a-philosophical-touch
  • Press release - 20/05/2008

    Bookmarks in the human book of life

    Histone acetyltransferases HATs and their antagonists the histone deacetylases are important enzymes in epigenetic gene regulation. Scientists discovered new HAT inhibitors that are now being investigated for their potential as anti-cancer drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/bookmarks-in-the-human-book-of-life
  • Article - 02/05/2008

    European-wide search for biomarkers of ageing

    Physical activity healthy nutrition more relaxation and no permanent sleep deficiency - is there a secret recipe for eternal youth? Alexander Bürkle from Constance along with scientists from all over Europe are aiming to identify the powerful biomarkers of human ageing.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-wide-search-for-biomarkers-of-ageing
  • Article - 01/05/2008

    Peter Öhlschläger - New strategies for the treatment of cancer

    Professor Peter Öhlschläger established his major scientific interests very early on. During his degree thesis at the German Cancer Research Centre DKFZ in Heidelberg the immunologist succeeded in combining his two major interests namely virology and cancer. Öhlschläger is now junior professor at the University of Constance and mainly deals with the development of therapeutic cancer vaccines.

    https://www.gesundheitsindustrie-bw.de/en/article/news/peter-hlschlaeger-new-strategies-for-the-treatment-of-cancer
  • Press release - 26/04/2008

    Curetis AG - Compact weapon against tuberculosis

    In conjunction with reference laboratories of the World Health Organization WHO medtech company Curetis AG is developing new technologies and products that identify the pathogens of infectious diseases such as tuberculosis and their resistance. The solutions are impressive.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-compact-weapon-against-tuberculosis
  • Article - 20/04/2008 varionostic CEO Uwe Gerstenmaier. (Photo: varionostic GmbH)

    varionostic develops test systems for tumour markers

    The Ulm-based company varionostic GmbH has received a research grant from the German Ministry of Economics and Technology. Details on the level of the grant were not disclosed. The company will research tumour markers and develop detection systems for DNA methylations.

    https://www.gesundheitsindustrie-bw.de/en/article/news/varionostic-develops-test-systems-for-tumour-markers
  • Press release - 17/04/2008

    BioLux GmbH - from the hen to the egg and then to the clients

    It began as a service laboratory for DNA sequencing and within a few years became a worldwide network of highly specialised biotech companies for molecular biology products. Investments in platform technologies play a key role in this development. Since then the team at Stuttgart-based BioLux GmbH has found that the production of antibodies is its highest revenue business activity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/biolux-gmbh-from-the-hen-to-the-egg-and-then-to-the-clients

Page 14 / 17

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • eine Seite zurück
  • Extend search to all portals
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2019 BIOPRO Baden-Württemberg
Website address: https://www.gesundheitsindustrie-bw.de/en/search